Horizon Investments LLC Raises Stock Position in McKesson Corporation $MCK

Key Points

• Horizon Investments LLC increased its stake in McKesson by 125.4% in Q4, adding 4,828 shares to hold 8,679 shares valued at about $7.12 million.
• McKesson beat Q-quarter expectations with $9.34 EPS vs $9.19 consensus and $106.16 billion in revenue (up 11.4% YoY), and set FY2026 guidance of 38.80–39.20 EPS (sell-side ~39.02).
• The company pays a quarterly dividend of $0.82 ($3.28 annual, yield ~0.4%, ex-dividend June 1) and has a consensus analyst rating of "Moderate Buy" with an average target of $972.27 versus the recent share price near $815.

Horizon Investments LLC increased its position in shares of McKesson Corporation (NYSE:MCK - Free Report) by 125.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 8,679 shares of the company's stock after acquiring an additional 4,828 shares during the period. Horizon Investments LLC's holdings in McKesson were worth $7,119,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. J.W. Cole Advisors Inc. raised its stake in McKesson by 35.3% during the third quarter. J.W. Cole Advisors Inc. now owns 5,089 shares of the company's stock valued at $3,931,000 after buying an additional 1,329 shares during the last quarter. Cullen Investment Group LTD. increased its holdings in shares of McKesson by 550.4% during the fourth quarter. Cullen Investment Group LTD. now owns 4,670 shares of the company's stock valued at $3,811,000 after acquiring an additional 3,952 shares in the last quarter. Private Wealth Partners LLC increased its holdings in shares of McKesson by 5.6% during the third quarter. Private Wealth Partners LLC now owns 31,841 shares of the company's stock valued at $24,598,000 after acquiring an additional 1,682 shares in the last quarter. AlphaQuest LLC raised its position in shares of McKesson by 91.2% in the 3rd quarter. AlphaQuest LLC now owns 1,767 shares of the company's stock worth $1,365,000 after purchasing an additional 843 shares during the last quarter. Finally, Envestnet Asset Management Inc. raised its position in shares of McKesson by 12.4% in the 3rd quarter. Envestnet Asset Management Inc. now owns 330,647 shares of the company's stock worth $255,438,000 after purchasing an additional 36,451 shares during the last quarter. 85.07% of the stock is owned by institutional investors.

McKesson Stock Down 0.1%

Shares of McKesson stock opened at $814.69 on Friday. McKesson Corporation has a twelve month low of $637.00 and a twelve month high of $999.00. The company's 50 day moving average is $894.86 and its 200 day moving average is $859.80. The company has a market cap of $99.79 billion, a price-to-earnings ratio of 23.43, a price-to-earnings-growth ratio of 1.18 and a beta of 0.35.

McKesson (NYSE:MCK - Get Free Report) last posted its earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping analysts' consensus estimates of $9.19 by $0.15. The business had revenue of $106.16 billion during the quarter, compared to the consensus estimate of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm's revenue was up 11.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Sell-side analysts expect that McKesson Corporation will post 39.02 EPS for the current fiscal year.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Investors of record on Monday, June 1st will be given a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Monday, June 1st. McKesson's dividend payout ratio is 9.43%.

Insider Transactions at McKesson

In other news, Director Maria Martinez sold 349 shares of the company's stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $939.87, for a total transaction of $328,014.63. Following the completion of the sale, the director owned 301 shares of the company's stock, valued at $282,900.87. This represents a 53.69% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $955.00, for a total transaction of $313,240.00. The SEC filing for this sale provides additional information. Insiders have sold a total of 3,592 shares of company stock worth $3,518,555 in the last three months. 0.08% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the stock. William Blair began coverage on shares of McKesson in a research report on Tuesday. They set an "outperform" rating on the stock. Wall Street Zen upgraded shares of McKesson from a "hold" rating to a "buy" rating in a research note on Saturday. TD Cowen increased their price target on shares of McKesson from $1,000.00 to $1,012.00 and gave the company a "buy" rating in a report on Thursday, February 5th. Evercore reissued an "outperform" rating on shares of McKesson in a research report on Thursday, March 5th. Finally, Raymond James Financial set a $970.00 price objective on shares of McKesson in a report on Thursday, March 5th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, McKesson has a consensus rating of "Moderate Buy" and an average target price of $972.27.

McKesson Profile

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.